Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue

Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous da...

Full description

Saved in:
Bibliographic Details
Published inRetrovirology Vol. 9; no. 1; p. 20
Main Authors Gonzalez-Perez, Maria Paz, O'Connell, Olivia, Lin, Rongheng, Sullivan, W Matthew, Bell, Jeanne, Simmonds, Peter, Clapham, Paul R
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 15.03.2012
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
AbstractList Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
BACKGROUNDTransmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. RESULTSAlmost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. CONCLUSIONSOur study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
Doc number: 20 Abstract Background: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Results: Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Conclusions: Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease with either an enhanced macrophage-tropism or carrying envelopes with an increased positive charge and fitness. In contrast, our previous data suggested that viruses carrying non-macrophage-tropic R5 envelopes were still predominant in immune tissue of AIDS patients. To further investigate the tropism and charge of HIV-1 viruses in late disease, we evaluated the properties of HIV-1 envelopes amplified from immune and brain tissues of AIDS patients with neurological complications. Almost all envelopes amplified were R5. There was clear compartmentalization of envelope sequences for four of the five subjects. However, strong compartmentalization of macrophage-tropism in brain was observed even when brain and immune tissue envelope sequences were not segregated. R5 envelopes from immune tissue of four subjects carried a higher positive charge compared to brain envelopes. We also confirm a significant correlation between macrophage tropism and sensitivity to soluble CD4, a weak association with sensitivity to the CD4 binding site antibody, b12, but no clear relationship with maraviroc sensitivity. Our study shows that non-macrophage-tropic R5 envelopes carrying gp120s with an increased positive charge were predominant in immune tissue in late disease. However, highly macrophage-tropic variants with lower charged gp120s were nearly universal in the brain. These results are consistent with HIV-1 R5 envelopes evolving gp120s with an increased positive charge in immune tissue or sites outside the brain that likely reflect an adaptation for increased replication or fitness for CD4+ T-cells. Our data are consistent with the presence of powerful pressures in brain and in immune tissues selecting for R5 envelopes with very different properties; high macrophage-tropism, sCD4 sensitivity and low positive charge in brain and non-macrophage-tropism, sCD4 resistance and high positive charge in immune tissue.
ArticleNumber 20
Audience Academic
Author Simmonds, Peter
Bell, Jeanne
Gonzalez-Perez, Maria Paz
O'Connell, Olivia
Sullivan, W Matthew
Lin, Rongheng
Clapham, Paul R
AuthorAffiliation 4 Centre for Infectious Diseases, Summerhall, Edinburgh EH9 1QH, UK
2 School of Public Health and Health Sciences, University of Massachusetts, 411 Arnold House, 715 North Pleasant Street, Amherst, MA 01003-9304
3 The MRC HIV brain and tissue bank in Edinburgh, Department of Pathology (Neuropathology), University of Edinburgh, Wilkie Building, Teviot Place, Edinburgh, UK EH8 9AG
1 Program in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, Massachusetts 01605-2377
AuthorAffiliation_xml – name: 3 The MRC HIV brain and tissue bank in Edinburgh, Department of Pathology (Neuropathology), University of Edinburgh, Wilkie Building, Teviot Place, Edinburgh, UK EH8 9AG
– name: 2 School of Public Health and Health Sciences, University of Massachusetts, 411 Arnold House, 715 North Pleasant Street, Amherst, MA 01003-9304
– name: 1 Program in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Biotech 2, 373 Plantation Street, Worcester, Massachusetts 01605-2377
– name: 4 Centre for Infectious Diseases, Summerhall, Edinburgh EH9 1QH, UK
Author_xml – sequence: 1
  givenname: Maria Paz
  surname: Gonzalez-Perez
  fullname: Gonzalez-Perez, Maria Paz
  organization: Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts 01605-2377, USA
– sequence: 2
  givenname: Olivia
  surname: O'Connell
  fullname: O'Connell, Olivia
– sequence: 3
  givenname: Rongheng
  surname: Lin
  fullname: Lin, Rongheng
– sequence: 4
  givenname: W Matthew
  surname: Sullivan
  fullname: Sullivan, W Matthew
– sequence: 5
  givenname: Jeanne
  surname: Bell
  fullname: Bell, Jeanne
– sequence: 6
  givenname: Peter
  surname: Simmonds
  fullname: Simmonds, Peter
– sequence: 7
  givenname: Paul R
  surname: Clapham
  fullname: Clapham, Paul R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22420378$$D View this record in MEDLINE/PubMed
BookMark eNp1ks-L1DAUx4usuD_06lECXrx0za-26UUYFnUHFgRRryFNXmYytMmYtLN48W833VnHHV0JJI9vvvkk7-WdFyc-eCiKlwRfEiLqt6ThtOR1i8u2pPhJcXYQTh7Ep8V5ShuMGRFYPCtOKeUUs0acFT-X3sAW8uRHBLvQT6MLHgWLBqVj2K7VCsoxBy4NSHmDnNcRVAKD9FrFFaAOxlsAj66X30qCPlcI_A76sIWEthHSzHUedVHl-Q4wDJMHNLqUJnhePLWqT_Difr0ovn54_-Xqurz59HF5tbgpuxq3YylMxS1pDeMNUcYwSzqrsmBxazVjkE3CcM1bbCra1VZkuWoAN0YT3tmaXRTLPdcEtZHb6AYVf8ignLwTQlxJFUene5BaWFHhuhWVVtx2osUdFcCI4g1QZnBmvduztlM3gNE5w6j6I-jxjndruQo7yVhNm5pkwGIP6Fz4D-B4R4dBzn8p57-UraTzI97cPyKG7xOkUQ4uaeh75SFMSRJMBOMs-7P19V_WTZiiz-WeXU3NmOD0j2ulchGctyFfrWeoXNCW0LZitciuy0dceRgYnM6taV3WHzuQmymlCPaQJsFy7uB_E3v1sLoH---WZb8A1-3t-A
CitedBy_id crossref_primary_10_1097_COH_0b013e32835fc601
crossref_primary_10_1007_s11481_015_9644_7
crossref_primary_10_1371_journal_ppat_1011974
crossref_primary_10_1371_journal_ppat_1007432
crossref_primary_10_1007_s13365_017_0586_0
crossref_primary_10_1128_JVI_01834_12
crossref_primary_10_1128_JVI_00946_15
crossref_primary_10_1093_icb_icab034
crossref_primary_10_1189_jlb_0713368
crossref_primary_10_3389_fcimb_2020_00261
crossref_primary_10_1128_JVI_00755_17
crossref_primary_10_1007_s11910_013_0387_7
crossref_primary_10_1186_s12977_015_0141_0
crossref_primary_10_1007_s13365_014_0291_1
crossref_primary_10_1016_j_immuni_2014_08_014
crossref_primary_10_1073_pnas_1917034117
crossref_primary_10_1128_JVI_00841_17
crossref_primary_10_1186_1742_4690_9_82
crossref_primary_10_1371_journal_ppat_1010335
crossref_primary_10_1007_s13365_018_0633_5
crossref_primary_10_1007_s13365_024_01207_w
crossref_primary_10_1007_s00705_018_4094_1
crossref_primary_10_1189_jlb_0612308
crossref_primary_10_1097_QAD_0000000000002616
crossref_primary_10_1371_journal_ppat_1005988
crossref_primary_10_1097_QAD_0b013e3283639804
crossref_primary_10_1128_JVI_01202_21
crossref_primary_10_1084_jem_20161190
crossref_primary_10_1002_9780471729259_mc15j01s28
crossref_primary_10_1186_s12977_015_0176_2
crossref_primary_10_1016_j_jviromet_2016_07_019
crossref_primary_10_3390_v15030590
Cites_doi 10.1128/JVI.76.12.6277-6292.2002
10.1089/aid.2005.21.706
10.3109/13550289609146909
10.1186/1742-4690-6-69
10.1128/JVI.75.21.10073-10089.2001
10.1099/0022-1317-83-8-1809
10.1128/JVI.02328-05
10.1089/aid.2010.0359
10.1212/WNL.42.9.1736
10.1212/WNL.44.3_Part_1.474
10.1038/sj.cdd.4401623
10.1001/archneurol.2010.84
10.1016/j.virol.2006.09.036
10.1128/JVI.02187-10
10.1097/00002030-199509000-00004
10.1016/S0960-5428(06)80268-8
10.1016/j.virol.2005.04.034
10.3109/13550280009091950
10.1016/S0140-6736(89)92628-7
10.1002/ana.20304
10.1002/(SICI)1097-0258(20000215)19:3<389::AID-SIM326>3.0.CO;2-J
10.1093/nar/25.24.4876
10.1016/j.virol.2008.06.014
10.1080/135502801753248114
10.1128/JVI.00131-11
10.1038/35073667
10.1128/JVI.79.8.5203-5210.2005
10.1128/JVI.78.21.11807-11815.2004
10.1128/JVI.02585-07
10.1089/aid.1998.14.25
10.1089/088922202753519133
10.1128/JVI.02133-08
10.2217/fvl.10.34
10.1038/nm1197-1259
10.1128/jvi.71.4.2928-2933.1997
10.1089/vim.1991.4.123
10.1128/AAC.46.6.1896-1905.2002
10.18637/jss.v012.i05
10.1016/j.virol.2007.05.029
10.1371/journal.ppat.1002286
10.1128/JVI.76.8.4138-4144.2002
10.1007/s11904-010-0042-8
10.1038/nri1527
10.1099/vir.0.81111-0
10.1128/JVI.73.12.9741-9755.1999
10.1128/JVI.05170-11
10.1212/WNL.44.3_Part_1.481
10.1084/jem.20070567
10.1016/S0140-6736(96)10178-1
10.1002/ana.410380510
10.1186/1742-4690-5-5
10.1089/aid.2010.0177
10.1128/JVI.02068-09
10.1080/13550280390218706
10.1084/jem.20090378
10.1111/j.1750-3639.2002.tb00461.x
10.1186/1742-4690-8-67
10.1006/viro.1998.9141
10.1016/j.virol.2010.05.006
10.1089/aid.2008.0009
10.1093/hmg/8.10.1939
10.1016/S0002-9440(10)63767-4
10.1007/s004010051113
10.1097/00005072-199409000-00012
10.1128/JVI.79.17.11343-11352.2005
10.1073/pnas.0605513103
10.1016/0167-5699(95)80022-0
10.1093/infdis/168.4.818
10.1128/JVI.72.4.2855-2864.1998
10.1089/vim.2005.18.190
10.1128/JVI.78.18.10133-10148.2004
10.1073/pnas.0802203105
10.1016/S0140-6736(86)90169-8
10.1128/jvi.71.3.2059-2071.1997
10.1128/JVI.74.21.10074-10080.2000
10.1016/S0140-6736(94)91222-X
10.1084/jem.193.8.905
10.1093/molbev/msr121
10.1128/JVI.72.1.488-496.1998
10.1128/jvi.68.7.4400-4408.1994
10.1128/JVI.78.13.6915-6926.2004
10.1002/ana.410390606
10.1126/science.287.5453.602
10.1128/JVI.00296-09
10.1128/JVI.02006-06
ContentType Journal Article
Copyright COPYRIGHT 2012 BioMed Central Ltd.
2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2012 BioMed Central Ltd.
– notice: 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2012 Gonzalez-Perez et al; licensee BioMed Central Ltd. 2012 Gonzalez-Perez et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7U9
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/1742-4690-9-20
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Virology and AIDS Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Virology and AIDS Abstracts
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

CrossRef
MEDLINE

Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1742-4690
EndPage 20
ExternalDocumentID oai_doaj_org_article_c8f8506985ca4fb890b28e31a47e23d0
oai_biomedcentral_com_1742_4690_9_20
2672841041
A291295368
10_1186_1742_4690_9_20
22420378
Genre Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Edinburgh Scotland
GeographicLocations_xml – name: Edinburgh Scotland
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R24 NS45491
– fundername: NICHD NIH HHS
  grantid: R01 HD049273
– fundername: NIAID NIH HHS
  grantid: P01 AI082274
– fundername: NIAID NIH HHS
  grantid: R01 AI089334
– fundername: NIMH NIH HHS
  grantid: R24MH59724
– fundername: NIMH NIH HHS
  grantid: R24MH59745
– fundername: NIMH NIH HHS
  grantid: U01MH083506
– fundername: NIMH NIH HHS
  grantid: R01 MH64408
– fundername: NIAID NIH HHS
  grantid: P30-AI42845
– fundername: Wellcome Trust
  grantid: 095831
GroupedDBID ---
-A0
0R~
123
29P
2VQ
2WC
3V.
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
AFPKN
CITATION
ABVAZ
AFGXO
AFNRJ
7U9
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-b609t-8d54f19d3471add3f1bfaf19f09fc33e6098d4c490d52b6f89fc57e07dc14bf63
IEDL.DBID RPM
ISSN 1742-4690
IngestDate Fri Oct 04 13:00:59 EDT 2024
Tue Sep 17 20:47:58 EDT 2024
Wed May 22 07:15:44 EDT 2024
Tue Aug 27 04:52:50 EDT 2024
Thu Oct 10 17:33:49 EDT 2024
Thu Feb 22 23:24:33 EST 2024
Fri Feb 02 04:07:25 EST 2024
Thu Sep 12 18:37:32 EDT 2024
Wed Oct 16 01:00:07 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b609t-8d54f19d3471add3f1bfaf19f09fc33e6098d4c490d52b6f89fc57e07dc14bf63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362761/
PMID 22420378
PQID 1017633842
PQPubID 54665
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_c8f8506985ca4fb890b28e31a47e23d0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3362761
biomedcentral_primary_oai_biomedcentral_com_1742_4690_9_20
proquest_miscellaneous_1018343690
proquest_journals_1017633842
gale_infotracmisc_A291295368
gale_infotracacademiconefile_A291295368
crossref_primary_10_1186_1742_4690_9_20
pubmed_primary_22420378
PublicationCentury 2000
PublicationDate 2012-03-15
PublicationDateYYYYMMDD 2012-03-15
PublicationDate_xml – month: 03
  year: 2012
  text: 2012-03-15
  day: 15
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Retrovirology
PublicationTitleAlternate Retrovirology
PublicationYear 2012
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 10649304 - Stat Med. 2000 Feb 15;19(3):389-404
17182681 - J Virol. 2007 Mar;81(5):2359-71
21159865 - J Virol. 2011 Mar;85(5):2397-405
8376829 - J Infect Dis. 1993 Oct;168(4):818-24
11175322 - J Neurovirol. 2000 Dec;6(6):498-506
15630430 - Nat Rev Immunol. 2005 Jan;5(1):69-81
15479822 - J Virol. 2004 Nov;78(21):11807-15
21843318 - Retrovirology. 2011;8:67
12408230 - Brain Pathol. 2002 Oct;12(4):442-55
7874396 - Adv Neuroimmunol. 1994;4(3):283-5
21226626 - AIDS Res Hum Retroviruses. 2011 Aug;27(8):889-901
19487424 - J Exp Med. 2009 Jun 8;206(6):1273-89
21546353 - Mol Biol Evol. 2011 Oct;28(10):2731-9
10871768 - J Neurovirol. 2000 May;6 Suppl 1:S70-81
19129457 - J Virol. 2009 Mar;83(6):2575-83
7515972 - J Virol. 1994 Jul;68(7):4400-8
11581376 - J Virol. 2001 Nov;75(21):10073-89
18788913 - AIDS Res Hum Retroviruses. 2008 Sep;24(9):1215-20
10559284 - J Virol. 1999 Dec;73(12):9741-55
15802963 - Viral Immunol. 2005;18(1):190-6
9060651 - J Virol. 1997 Apr;71(4):2928-33
11704885 - J Neurovirol. 2001 Dec;7(6):528-41
10541871 - Acta Neuropathol. 1999 Nov;98(5):481-7
8527071 - AIDS. 1995 Sep;9(9):1001-8
8972425 - J Neurovirol. 1996 Dec;2(6):423-32
18205925 - Retrovirology. 2008;5:5
7905551 - Lancet. 1994 Feb 12;343(8894):383-5
7546209 - Immunol Today. 1995 Sep;16(9):441-8
16131310 - AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13
11309629 - Nature. 2001 Apr 19;410(6831):988-94
21471230 - J Virol. 2011 Jun;85(12):6024-37
21314481 - AIDS Res Hum Retroviruses. 2011 Sep;27(9):965-7
9614862 - Virology. 1998 May 25;245(1):1-10
12019106 - Antimicrob Agents Chemother. 2002 Jun;46(6):1896-905
15795303 - J Virol. 2005 Apr;79(8):5203-10
1684709 - Viral Immunol. 1991 Summer;4(2):123-31
16775320 - J Virol. 2006 Jul;80(13):6324-32
9359702 - Nat Med. 1997 Nov;3(11):1259-65
18490657 - Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
15161643 - Am J Pathol. 2004 Jun;164(6):2089-99
8083694 - J Neuropathol Exp Neurol. 1994 Sep;53(5):521-34
20147398 - J Virol. 2010 Apr;84(8):4100-4
7486867 - Ann Neurol. 1995 Nov;38(5):755-62
11024136 - J Virol. 2000 Nov;74(21):10074-80
15331746 - J Virol. 2004 Sep;78(18):10133-48
17015824 - Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15160-5
10469847 - Hum Mol Genet. 1999;8(10):1939-45
15194768 - J Virol. 2004 Jul;78(13):6915-26
18385254 - J Virol. 2008 Jun;82(12):5807-14
9078201 - Lancet. 1997 Mar 8;349(9053):692-5
18672260 - Virology. 2008 Sep 15;379(1):125-34
8145919 - Neurology. 1994 Mar;44(3 Pt 1):481-7
12907388 - J Neurovirol. 2003 Aug;9(4):432-41
11304551 - J Exp Med. 2001 Apr 16;193(8):905-15
2429124 - Lancet. 1986 Sep 20;2(8508):660-2
11897037 - AIDS Res Hum Retroviruses. 2002 Mar 20;18(5):353-62
8145918 - Neurology. 1994 Mar;44(3 Pt 1):474-81
17599380 - Virology. 2007 Oct 10;367(1):222-34
9525605 - J Virol. 1998 Apr;72(4):2855-64
22007152 - PLoS Pathog. 2011 Oct;7(10):e1002286
16186242 - J Gen Virol. 2005 Oct;86(Pt 10):2859-69
9396791 - Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
2565516 - Lancet. 1989 May 6;1(8645):983-5
12124446 - J Gen Virol. 2002 Aug;83(Pt 8):1809-29
15832177 - Cell Death Differ. 2005 Aug;12 Suppl 1:878-92
9453248 - AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):25-30
17084877 - Virology. 2007 Mar 30;360(1):105-19
17724130 - J Exp Med. 2007 Sep 3;204(9):2171-85
1513462 - Neurology. 1992 Sep;42(9):1736-9
20570309 - Virology. 2010 Sep 1;404(2):269-78
21795326 - J Virol. 2011 Oct;85(19):9824-33
9420250 - J Virol. 1998 Jan;72(1):488-96
11907256 - J Virol. 2002 Apr;76(8):4138-44
9032338 - J Virol. 1997 Mar;71(3):2059-71
20930940 - Future Virol. 2010 Jul;5(4):435-451
19515785 - J Virol. 2009 Aug;83(16):8208-20
9932303 - Rev Neurol (Paris). 1998 Dec;154(12):816-29
15562411 - Ann Neurol. 2004 Dec;56(6):873-7
15916792 - Virology. 2005 Jul 5;337(2):384-98
8651642 - Ann Neurol. 1996 Jun;39(6):705-11
10691542 - Science. 2000 Jan 28;287(5453):602-4
20425562 - Curr HIV/AIDS Rep. 2010 May;7(2):85-91
16103186 - J Virol. 2005 Sep;79(17):11343-52
20517932 - Ann Neurol. 2010 Jun;67(6):699-714
19619305 - Retrovirology. 2009;6:69
12021361 - J Virol. 2002 Jun;76(12):6277-92
LR Sharer (2864_CR61) 1994; 4
M Alexander (2864_CR3) 2010; 84
A Okoye (2864_CR64) 2007; 204
PJ Peters (2864_CR52) 2008; 5
A Ranki (2864_CR59) 1995; 9
M Salemi (2864_CR47) 2005; 79
A Revilla (2864_CR77) 2011; 27
BF Keele (2864_CR78) 2008; 105
L Gillim-Ross (2864_CR58) 2005; 18
U O'Doherty (2864_CR84) 2000; 74
S Haggerty (2864_CR45) 1991; 4
TC Pierson (2864_CR57) 2002; 76
J Sterjovski (2864_CR74) 2010; 404
SF An (2864_CR40) 1999; 98
M Kaul (2864_CR20) 2005; 12
G Gosztonyi (2864_CR29) 1994; 53
J Isaacman-Beck (2864_CR76) 2009; 83
V Tozzi (2864_CR24) 2005; 21
J Repits (2864_CR16) 2005; 86
L Gray (2864_CR9) 2005; 337
T Fischer-Smith (2864_CR37) 2004; 164
Y Yi (2864_CR55) 2003; 9
JK Wong (2864_CR44) 1997; 71
S Li (2864_CR10) 1999; 73
RL Dunfee (2864_CR67) 2007; 367
M Tersmette (2864_CR8) 1989; 1
PR Gorry (2864_CR51) 2002; 76
M Sharkey (2864_CR56) 2005; 79
G Scarlatti (2864_CR7) 1997; 3
JF Salazar-Gonzalez (2864_CR2) 2009; 206
J Takehisa (2864_CR79) 1998; 245
JD Glass (2864_CR33) 1995; 38
C Ritz (2864_CR87) 2005; 12
H Chen (2864_CR49) 2000; 6
RL Dunfee (2864_CR69) 2009; 6
X Wei (2864_CR82) 2002; 46
PJ Peters (2864_CR12) 2004; 78
YK Donaldson (2864_CR27) 1994; 343
JE Bell (2864_CR26) 1993; 168
C Tornatore (2864_CR62) 1994; 44
T Musich (2864_CR72) 2011; 85
G Schnell (2864_CR73) 2011; 7
J Chang (2864_CR43) 1998; 14
PJ Peters (2864_CR13) 2006; 80
ME Mefford (2864_CR54) 2008; 24
MA Cosenza (2864_CR41) 2002; 12
KJ Liner II (2864_CR22) 2010; 7
KC Williams (2864_CR35) 2001; 193
K Tamura (2864_CR81) 2011; 28
QJ Nottingham (2864_CR86) 2000; 19
S Gartner (2864_CR32) 2000; 287
J Guo (2864_CR85) 2011; 85
Y Liu (2864_CR31) 2000; 6
B Asjo (2864_CR5) 1986; 2
LE Davis (2864_CR25) 1992; 42
ER Thomas (2864_CR53) 2007; 360
RJ Brown (2864_CR71) 2011; 85
DL Tuttle (2864_CR11) 2002; 18
E Seclen (2864_CR17) 2011; 27
RL Dunfee (2864_CR65) 2006; 103
F Gonzalez-Scarano (2864_CR19) 2005; 5
TK Smit (2864_CR48) 2004; 78
Y Saito (2864_CR60) 1994; 44
I Teo (2864_CR28) 1997; 71
JE Bell (2864_CR39) 1998; 154
AB Van't Wout (2864_CR46) 1998; 72
M Westby (2864_CR70) 2007; 81
EJ Platt (2864_CR83) 1998; 72
MJ Duenas-Decamp (2864_CR68) 2009; 83
MJ Duenas-Decamp (2864_CR66) 2008; 82
JD Thompson (2864_CR80) 1997; 25
L Pulliam (2864_CR42) 1997; 349
KA Thompson (2864_CR63) 2004; 56
J Repits (2864_CR15) 2008; 379
T Fischer-Smith (2864_CR36) 2001; 7
K Takahashi (2864_CR38) 1996; 39
RI Connor (2864_CR6) 1994; 68
PR Gorry (2864_CR50) 2001; 75
M Kaul (2864_CR21) 2001; 410
M Carrington (2864_CR1) 1999; 8
HS Nottet (2864_CR30) 1995; 16
JH Lane (2864_CR34) 1996; 2
M Kishko (2864_CR4) 2011; 8
MJ Duenas-Decamp (2864_CR18) 2010; 5
I Karlsson (2864_CR14) 2004; 78
JC McArthur (2864_CR23) 2010; 67
PR Clapham (2864_CR75) 2002; 83
References_xml – volume: 76
  start-page: 6277
  year: 2002
  ident: 2864_CR51
  publication-title: J Virol
  doi: 10.1128/JVI.76.12.6277-6292.2002
  contributor:
    fullname: PR Gorry
– volume: 6
  start-page: S70
  issue: Suppl 1
  year: 2000
  ident: 2864_CR31
  publication-title: J Neurovirol
  contributor:
    fullname: Y Liu
– volume: 21
  start-page: 706
  year: 2005
  ident: 2864_CR24
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2005.21.706
  contributor:
    fullname: V Tozzi
– volume: 2
  start-page: 423
  year: 1996
  ident: 2864_CR34
  publication-title: J Neurovirol
  doi: 10.3109/13550289609146909
  contributor:
    fullname: JH Lane
– volume: 6
  start-page: 69
  year: 2009
  ident: 2864_CR69
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-6-69
  contributor:
    fullname: RL Dunfee
– volume: 75
  start-page: 10073
  year: 2001
  ident: 2864_CR50
  publication-title: J Virol
  doi: 10.1128/JVI.75.21.10073-10089.2001
  contributor:
    fullname: PR Gorry
– volume: 83
  start-page: 1809
  year: 2002
  ident: 2864_CR75
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-83-8-1809
  contributor:
    fullname: PR Clapham
– volume: 80
  start-page: 6324
  year: 2006
  ident: 2864_CR13
  publication-title: J Virol
  doi: 10.1128/JVI.02328-05
  contributor:
    fullname: PJ Peters
– volume: 27
  start-page: 965
  year: 2011
  ident: 2864_CR17
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2010.0359
  contributor:
    fullname: E Seclen
– volume: 42
  start-page: 1736
  year: 1992
  ident: 2864_CR25
  publication-title: Neurology
  doi: 10.1212/WNL.42.9.1736
  contributor:
    fullname: LE Davis
– volume: 44
  start-page: 474
  year: 1994
  ident: 2864_CR60
  publication-title: Neurology
  doi: 10.1212/WNL.44.3_Part_1.474
  contributor:
    fullname: Y Saito
– volume: 12
  start-page: 878
  issue: Suppl 1
  year: 2005
  ident: 2864_CR20
  publication-title: Cell Death Differ
  doi: 10.1038/sj.cdd.4401623
  contributor:
    fullname: M Kaul
– volume: 67
  start-page: 699
  year: 2010
  ident: 2864_CR23
  publication-title: Ann Neurol
  doi: 10.1001/archneurol.2010.84
  contributor:
    fullname: JC McArthur
– volume: 360
  start-page: 105
  year: 2007
  ident: 2864_CR53
  publication-title: Virology
  doi: 10.1016/j.virol.2006.09.036
  contributor:
    fullname: ER Thomas
– volume: 85
  start-page: 2397
  year: 2011
  ident: 2864_CR72
  publication-title: J Virol
  doi: 10.1128/JVI.02187-10
  contributor:
    fullname: T Musich
– volume: 9
  start-page: 1001
  year: 1995
  ident: 2864_CR59
  publication-title: AIDS
  doi: 10.1097/00002030-199509000-00004
  contributor:
    fullname: A Ranki
– volume: 4
  start-page: 283
  year: 1994
  ident: 2864_CR61
  publication-title: Adv Neuroimmunol
  doi: 10.1016/S0960-5428(06)80268-8
  contributor:
    fullname: LR Sharer
– volume: 337
  start-page: 384
  year: 2005
  ident: 2864_CR9
  publication-title: Virology
  doi: 10.1016/j.virol.2005.04.034
  contributor:
    fullname: L Gray
– volume: 6
  start-page: 498
  year: 2000
  ident: 2864_CR49
  publication-title: J Neurovirol
  doi: 10.3109/13550280009091950
  contributor:
    fullname: H Chen
– volume: 1
  start-page: 983
  year: 1989
  ident: 2864_CR8
  publication-title: Lancet
  doi: 10.1016/S0140-6736(89)92628-7
  contributor:
    fullname: M Tersmette
– volume: 56
  start-page: 873
  year: 2004
  ident: 2864_CR63
  publication-title: Ann Neurol
  doi: 10.1002/ana.20304
  contributor:
    fullname: KA Thompson
– volume: 19
  start-page: 389
  year: 2000
  ident: 2864_CR86
  publication-title: Stat Med
  doi: 10.1002/(SICI)1097-0258(20000215)19:3<389::AID-SIM326>3.0.CO;2-J
  contributor:
    fullname: QJ Nottingham
– volume: 25
  start-page: 4876
  year: 1997
  ident: 2864_CR80
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/25.24.4876
  contributor:
    fullname: JD Thompson
– volume: 379
  start-page: 125
  year: 2008
  ident: 2864_CR15
  publication-title: Virology
  doi: 10.1016/j.virol.2008.06.014
  contributor:
    fullname: J Repits
– volume: 7
  start-page: 528
  year: 2001
  ident: 2864_CR36
  publication-title: J Neurovirol
  doi: 10.1080/135502801753248114
  contributor:
    fullname: T Fischer-Smith
– volume: 85
  start-page: 6024
  year: 2011
  ident: 2864_CR71
  publication-title: J Virol
  doi: 10.1128/JVI.00131-11
  contributor:
    fullname: RJ Brown
– volume: 410
  start-page: 988
  year: 2001
  ident: 2864_CR21
  publication-title: Nature
  doi: 10.1038/35073667
  contributor:
    fullname: M Kaul
– volume: 79
  start-page: 5203
  year: 2005
  ident: 2864_CR56
  publication-title: J Virol
  doi: 10.1128/JVI.79.8.5203-5210.2005
  contributor:
    fullname: M Sharkey
– volume: 78
  start-page: 11807
  year: 2004
  ident: 2864_CR14
  publication-title: J Virol
  doi: 10.1128/JVI.78.21.11807-11815.2004
  contributor:
    fullname: I Karlsson
– volume: 82
  start-page: 5807
  year: 2008
  ident: 2864_CR66
  publication-title: J Virol
  doi: 10.1128/JVI.02585-07
  contributor:
    fullname: MJ Duenas-Decamp
– volume: 14
  start-page: 25
  year: 1998
  ident: 2864_CR43
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.1998.14.25
  contributor:
    fullname: J Chang
– volume: 18
  start-page: 353
  year: 2002
  ident: 2864_CR11
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/088922202753519133
  contributor:
    fullname: DL Tuttle
– volume: 83
  start-page: 2575
  year: 2009
  ident: 2864_CR68
  publication-title: J Virol
  doi: 10.1128/JVI.02133-08
  contributor:
    fullname: MJ Duenas-Decamp
– volume: 5
  start-page: 417
  year: 2010
  ident: 2864_CR18
  publication-title: Future Virology
  doi: 10.2217/fvl.10.34
  contributor:
    fullname: MJ Duenas-Decamp
– volume: 3
  start-page: 1259
  year: 1997
  ident: 2864_CR7
  publication-title: Nat Med
  doi: 10.1038/nm1197-1259
  contributor:
    fullname: G Scarlatti
– volume: 71
  start-page: 2928
  year: 1997
  ident: 2864_CR28
  publication-title: J Virol
  doi: 10.1128/jvi.71.4.2928-2933.1997
  contributor:
    fullname: I Teo
– volume: 154
  start-page: 816
  year: 1998
  ident: 2864_CR39
  publication-title: Rev Neurol (Paris)
  contributor:
    fullname: JE Bell
– volume: 4
  start-page: 123
  year: 1991
  ident: 2864_CR45
  publication-title: Viral Immunol
  doi: 10.1089/vim.1991.4.123
  contributor:
    fullname: S Haggerty
– volume: 46
  start-page: 1896
  year: 2002
  ident: 2864_CR82
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/AAC.46.6.1896-1905.2002
  contributor:
    fullname: X Wei
– volume: 12
  start-page: 1
  year: 2005
  ident: 2864_CR87
  publication-title: J Stat Softw
  doi: 10.18637/jss.v012.i05
  contributor:
    fullname: C Ritz
– volume: 367
  start-page: 222
  year: 2007
  ident: 2864_CR67
  publication-title: Virology
  doi: 10.1016/j.virol.2007.05.029
  contributor:
    fullname: RL Dunfee
– volume: 7
  start-page: e1002286
  year: 2011
  ident: 2864_CR73
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002286
  contributor:
    fullname: G Schnell
– volume: 76
  start-page: 4138
  year: 2002
  ident: 2864_CR57
  publication-title: J Virol
  doi: 10.1128/JVI.76.8.4138-4144.2002
  contributor:
    fullname: TC Pierson
– volume: 7
  start-page: 85
  year: 2010
  ident: 2864_CR22
  publication-title: Curr HIV/AIDS Rep
  doi: 10.1007/s11904-010-0042-8
  contributor:
    fullname: KJ Liner II
– volume: 5
  start-page: 69
  year: 2005
  ident: 2864_CR19
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1527
  contributor:
    fullname: F Gonzalez-Scarano
– volume: 86
  start-page: 2859
  year: 2005
  ident: 2864_CR16
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.81111-0
  contributor:
    fullname: J Repits
– volume: 73
  start-page: 9741
  year: 1999
  ident: 2864_CR10
  publication-title: J Virol
  doi: 10.1128/JVI.73.12.9741-9755.1999
  contributor:
    fullname: S Li
– volume: 85
  start-page: 9824
  year: 2011
  ident: 2864_CR85
  publication-title: J Virol
  doi: 10.1128/JVI.05170-11
  contributor:
    fullname: J Guo
– volume: 44
  start-page: 481
  year: 1994
  ident: 2864_CR62
  publication-title: Neurology
  doi: 10.1212/WNL.44.3_Part_1.481
  contributor:
    fullname: C Tornatore
– volume: 204
  start-page: 2171
  year: 2007
  ident: 2864_CR64
  publication-title: J Exp Med
  doi: 10.1084/jem.20070567
  contributor:
    fullname: A Okoye
– volume: 349
  start-page: 692
  year: 1997
  ident: 2864_CR42
  publication-title: Lancet
  doi: 10.1016/S0140-6736(96)10178-1
  contributor:
    fullname: L Pulliam
– volume: 38
  start-page: 755
  year: 1995
  ident: 2864_CR33
  publication-title: Ann Neurol
  doi: 10.1002/ana.410380510
  contributor:
    fullname: JD Glass
– volume: 5
  start-page: 5
  year: 2008
  ident: 2864_CR52
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-5-5
  contributor:
    fullname: PJ Peters
– volume: 27
  start-page: 889
  year: 2011
  ident: 2864_CR77
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2010.0177
  contributor:
    fullname: A Revilla
– volume: 84
  start-page: 4100
  year: 2010
  ident: 2864_CR3
  publication-title: J Virol
  doi: 10.1128/JVI.02068-09
  contributor:
    fullname: M Alexander
– volume: 9
  start-page: 432
  year: 2003
  ident: 2864_CR55
  publication-title: J Neurovirol
  doi: 10.1080/13550280390218706
  contributor:
    fullname: Y Yi
– volume: 206
  start-page: 1273
  year: 2009
  ident: 2864_CR2
  publication-title: J Exp Med
  doi: 10.1084/jem.20090378
  contributor:
    fullname: JF Salazar-Gonzalez
– volume: 12
  start-page: 442
  year: 2002
  ident: 2864_CR41
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.2002.tb00461.x
  contributor:
    fullname: MA Cosenza
– volume: 8
  start-page: 67
  year: 2011
  ident: 2864_CR4
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-8-67
  contributor:
    fullname: M Kishko
– volume: 245
  start-page: 1
  year: 1998
  ident: 2864_CR79
  publication-title: Virology
  doi: 10.1006/viro.1998.9141
  contributor:
    fullname: J Takehisa
– volume: 404
  start-page: 269
  year: 2010
  ident: 2864_CR74
  publication-title: Virology
  doi: 10.1016/j.virol.2010.05.006
  contributor:
    fullname: J Sterjovski
– volume: 24
  start-page: 1215
  year: 2008
  ident: 2864_CR54
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2008.0009
  contributor:
    fullname: ME Mefford
– volume: 8
  start-page: 1939
  year: 1999
  ident: 2864_CR1
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/8.10.1939
  contributor:
    fullname: M Carrington
– volume: 164
  start-page: 2089
  year: 2004
  ident: 2864_CR37
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)63767-4
  contributor:
    fullname: T Fischer-Smith
– volume: 98
  start-page: 481
  year: 1999
  ident: 2864_CR40
  publication-title: Acta Neuropathol (Berl)
  doi: 10.1007/s004010051113
  contributor:
    fullname: SF An
– volume: 53
  start-page: 521
  year: 1994
  ident: 2864_CR29
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/00005072-199409000-00012
  contributor:
    fullname: G Gosztonyi
– volume: 79
  start-page: 11343
  year: 2005
  ident: 2864_CR47
  publication-title: J Virol
  doi: 10.1128/JVI.79.17.11343-11352.2005
  contributor:
    fullname: M Salemi
– volume: 103
  start-page: 15160
  year: 2006
  ident: 2864_CR65
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0605513103
  contributor:
    fullname: RL Dunfee
– volume: 16
  start-page: 441
  year: 1995
  ident: 2864_CR30
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(95)80022-0
  contributor:
    fullname: HS Nottet
– volume: 168
  start-page: 818
  year: 1993
  ident: 2864_CR26
  publication-title: J Infect Dis
  doi: 10.1093/infdis/168.4.818
  contributor:
    fullname: JE Bell
– volume: 72
  start-page: 2855
  year: 1998
  ident: 2864_CR83
  publication-title: J Virol
  doi: 10.1128/JVI.72.4.2855-2864.1998
  contributor:
    fullname: EJ Platt
– volume: 18
  start-page: 190
  year: 2005
  ident: 2864_CR58
  publication-title: Viral Immunol
  doi: 10.1089/vim.2005.18.190
  contributor:
    fullname: L Gillim-Ross
– volume: 78
  start-page: 10133
  year: 2004
  ident: 2864_CR48
  publication-title: J Virol
  doi: 10.1128/JVI.78.18.10133-10148.2004
  contributor:
    fullname: TK Smit
– volume: 105
  start-page: 7552
  year: 2008
  ident: 2864_CR78
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0802203105
  contributor:
    fullname: BF Keele
– volume: 2
  start-page: 660
  year: 1986
  ident: 2864_CR5
  publication-title: Lancet
  doi: 10.1016/S0140-6736(86)90169-8
  contributor:
    fullname: B Asjo
– volume: 71
  start-page: 2059
  year: 1997
  ident: 2864_CR44
  publication-title: J Virol
  doi: 10.1128/jvi.71.3.2059-2071.1997
  contributor:
    fullname: JK Wong
– volume: 74
  start-page: 10074
  year: 2000
  ident: 2864_CR84
  publication-title: J Virol
  doi: 10.1128/JVI.74.21.10074-10080.2000
  contributor:
    fullname: U O'Doherty
– volume: 343
  start-page: 383
  year: 1994
  ident: 2864_CR27
  publication-title: Lancet
  doi: 10.1016/S0140-6736(94)91222-X
  contributor:
    fullname: YK Donaldson
– volume: 193
  start-page: 905
  year: 2001
  ident: 2864_CR35
  publication-title: J Exp Med
  doi: 10.1084/jem.193.8.905
  contributor:
    fullname: KC Williams
– volume: 28
  start-page: 2731
  year: 2011
  ident: 2864_CR81
  publication-title: Mol Biol Evol
  doi: 10.1093/molbev/msr121
  contributor:
    fullname: K Tamura
– volume: 72
  start-page: 488
  year: 1998
  ident: 2864_CR46
  publication-title: J Virol
  doi: 10.1128/JVI.72.1.488-496.1998
  contributor:
    fullname: AB Van't Wout
– volume: 68
  start-page: 4400
  year: 1994
  ident: 2864_CR6
  publication-title: J Virol
  doi: 10.1128/jvi.68.7.4400-4408.1994
  contributor:
    fullname: RI Connor
– volume: 78
  start-page: 6915
  year: 2004
  ident: 2864_CR12
  publication-title: J Virol
  doi: 10.1128/JVI.78.13.6915-6926.2004
  contributor:
    fullname: PJ Peters
– volume: 39
  start-page: 705
  year: 1996
  ident: 2864_CR38
  publication-title: Ann Neurol
  doi: 10.1002/ana.410390606
  contributor:
    fullname: K Takahashi
– volume: 287
  start-page: 602
  year: 2000
  ident: 2864_CR32
  publication-title: Science
  doi: 10.1126/science.287.5453.602
  contributor:
    fullname: S Gartner
– volume: 83
  start-page: 8208
  year: 2009
  ident: 2864_CR76
  publication-title: J Virol
  doi: 10.1128/JVI.00296-09
  contributor:
    fullname: J Isaacman-Beck
– volume: 81
  start-page: 2359
  year: 2007
  ident: 2864_CR70
  publication-title: J Virol
  doi: 10.1128/JVI.02006-06
  contributor:
    fullname: M Westby
SSID ssj0031808
Score 2.2256863
Snippet Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in late disease...
Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5...
Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in...
Doc number: 20 Abstract Background: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have...
BACKGROUNDTransmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in...
BACKGROUND: Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5 viruses in...
Abstract Background Transmitted HIV-1 clade B or C R5 viruses have been reported to infect macrophages inefficiently, while other studies have described R5...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 20
SubjectTerms Acquired immune deficiency syndrome
Acquired Immunodeficiency Syndrome - immunology
Acquired Immunodeficiency Syndrome - virology
Adaptation, Biological
AIDS
Brain
Brain - immunology
Brain - virology
CCR5
CD4
Confidence intervals
Dementia
Disease
Entry
Envelope
Health sciences
HIV
HIV Envelope Protein gp120 - chemistry
HIV Envelope Protein gp120 - genetics
HIV-1 - genetics
HIV-1 - growth & development
HIV-1 - pathogenicity
HIV-1 - physiology
Human immunodeficiency virus
Humans
Immune tissue
Macrophage-tropism
Macrophages - virology
Molecular Sequence Data
Neurotropism
Phylogenetics
Selection, Genetic
Sequence Analysis, DNA
Spleen
Statistical methods
Studies
Viral Tropism
SummonAdditionalLinks – databaseName: BioMed Central
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCIkL4s1CQUZC4hQRP5I43FpEtUWCA6Ko4mL5MVZXotmKTZG48NuZSbKh7h65RfbYsTMPj53xN4y9NtKnqEUsXNKq0E3whVfgUONDG2RpQACdQ376XC9P9MfT6vTfece1P_jC1G_RZZYFbeKKFll6k92SBHFO-_LD71ubi4I55J6baSd4xt321-61_8iWowG1f9c2X1mc8sDJKyvR0T12d3Ih-cHI8_vsBnQP2O0xqeTvh-zP8ZzZtufwaxItvk783FG-rjO0IEWPD6vNOXdd5KuOPMcNRD7AJgGfYrf48vhbIfiXikM3RBbBhl-Mt5WwDfeUXGLsgO6YAO8HHj5iJ0cfvr5fFlOWhcLXZdsXJlY6iTYqXKbQ2KkkfHJYkMo2BaUAiUzUQbdlrKSvk8HiqoGyiUFon2r1mO116w6eMl7RbqiEkJBQl9o530Qvg9NQC4heLNi77OPbixFRwxLGdV6D6maJc5Y4Z1srywV7s-XU3G7YwZh6h_KQGJn1PhSgWNlJIW0wicD6WlPh-JI3bemlASWcbkCqSK8jMbCk5zii4KbrCjhTQsyyB7JFV6lStVmw_YwS9TPk1VtBspN92FBgHRp2ZbRcsFdzNbWkmLcO1pcDjVFa4awW7Mkod_OU0PGSpWqw8yaTyGzOeU23OhvQwxW6LE0tnv0PL56zO-g4SorFE9U-2-t_XsILdM56_3LQy78SsThJ
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixQxEA6yIHgR37auEkHwFLbz6O7E2yous4IexJW9hTzZAbdn2ekVvPjbreruaSbswYu3IalkplKPVA2Vrwh5q4XPUfHIXFaSqS545mVyYPHBBFHrxBP-D_nla7s6U5_Pm_O9Vl9YEzbBA08HdxR0RlA1o5vgVPba1F7oJLlTXRIyTtk6b3bJ1OSDQVHHXnQQbguGCeAM18h1e7SMMcOwy3fxzv1ncT2NKP63ffXeZVUWUu7dTCcPyP05pKTHEysPyZ3UPyJ3pyaTvx-TP6dLp9uBpl-zqtFNppcO-3ddgEdhA3xYby-p6yNd9xhJblOkI4xSonMtF12d_mCcfmto6sdKo7SlV9PrJVhDPTabmDbANyeJDqNMn5Czk0_fP67Y3HWB-bY2A9OxUZmbKOHaAucnM_fZwUCuTQ5SJiDSUQVl6tgI32YNw02X6i4Grnxu5VNy0G_69JzQBrOjOoUMhKpWzvkuegFyTC1P0fOKvC8O315NCBsWMa_LGTA_i5KzKDlrrKgr8m4nqWXdmNHo9hblBxRksfs4AHpmZz2z_9Iz-DpUA4t2D78ouPn5AnCKCFr2WBgInRrZ6oocFpRgr6Gc3imSnf3FFgvtwNFLrURF3izTuBJr4Pq0uRlptFQSuKrIs0nvFpYgEBO17GDzrtDIgudypl9fjGjiEkKYruUv_schvST3IKAUWKPHm0NyMFzfpFcQtA3-9WiffwHneEAq
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA9aEXwRvz2tEkHwKTRfu5v1RapYroI-iJV7C5sve9Dunb2t4It_uzO7ubOh4NuRTHLJzW8mM7nJDCGvjXQpaBFYl7RiuvGOORU7kHjfeslNFBHvIT9_qecn-tOiWuQLt00Oq9zqxFFRh5XHO_IDhE4N_pSW79Y_GVaNwn9XcwmNm-SWgIkR581i53ABXLnJiRqFqQ_A-JYM3UHWMqzvXbxwPysOpjF__3UtfeWYKkMor5xJR_fI3WxM0sOJ-_fJjdg_ILen8pK_H5I_x7satwONvzLI6CrR8w4rd52CLmEDfFhuzmnXB7rs0YbcxEDHBEqR5iguOj_-zgT9WtHYjzFGcUPX07slGEMdlpmYJsDXJpEOIzcfkZOjj98-zFmut8BczduBmVDpJNqg4MACtaeScKmDhsTb5JWKQGSC9rrloZKuTgaaqybyJnihXarVY7LXr_r4lNAK_SIefQJCzXXXuSY46TsdaxGDEzPytvjx7XrKrWEx23XZAyCwyDmLnLOtlXxG3mw5tRs3-jKmvkb5HhlZzD42rC5-2Cya1puEaftaU8H6kjMtd9JEJTrdRKkCfh3CwKLEw4p8lx8uwE4xd5Y9lC0YTZWqzYzsF5Qgqb7s3gLJZk2xsf9wPSOvdt04EqPf-ri6HGmM0gp2NSNPJtzttgQmmOSqgcmbApHFnsuefnk65hFXYLw0tXj2_2U9J3fASJQYdyeqfbI3XFzGF2CIDe7lKG1_AYGhNfM
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagCIkL4k2gICMhcQr4lcRBQqggqi1SOSAW9Wb5SVdqs2U3RfTCb2cmyYaG5cAtsseO7fnGnknGM4Q818KloHjIbVIyV5V3uZPRgsT72gumI4_4HfLwUzmbq49HxdEf_6dhAdf_NO0wn9R8dfLy5_eLtyDwbzqB1-UrUKpFjmZeXgPTr5JrQkmFaD9U4x8FgC7TQ9DG7TZ_3XY_mRxSXSz_7R370pE1dae8dD7t3yI3B8WS7vVIuE2uxOYOud6nmry4S34djPluWxp_DICjy0RPLWbxOoZ9JW_hYbE-pbYJdNGgPrmOgXbBlCIdPLro7OBrzunngsam8zeKa3rW32GCNtRhyom-A7x5EmnbcfYeme9_-PJ-lg-5F3JXsrrNdShU4nWQcHjBFigTd8lCQWJ18lJGINJBeVWzUAhXJg3FRRVZFTxXLpXyPtlplk18SGiBNhKLPgGhYspaVwUnvFWx5DE4npHXk8U3Z32cDYORr6c1IIQGOWeQc6Y2gmXkxYZTY7vOrtHlFuU7ZOSk965gufpmBjE1XicM4VfrAsaXnK6ZEzpKblUVhQz4OoSBQTzCiLwdLjHATDGOltkTNShQhSx1RnYnlCC1flq9AZLZgB7d7WC7l1qJjDwbq7ElesI1cXne0WipJMwqIw963I1TAnVMMFlB59UEkZM5T2uaxXEXU1yCIlOV_NF_vPcxuQFao0BHPF7skp12dR6fgGbWuqedyP0GjX06Mg
  priority: 102
  providerName: Scholars Portal
Title Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue
URI https://www.ncbi.nlm.nih.gov/pubmed/22420378
https://www.proquest.com/docview/1017633842
https://search.proquest.com/docview/1018343690
http://dx.doi.org/10.1186/1742-4690-9-20
https://pubmed.ncbi.nlm.nih.gov/PMC3362761
https://doaj.org/article/c8f8506985ca4fb890b28e31a47e23d0
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1La9swWLQdg13G3vPWBQ0GO7mRJdmWd2tKSzpIKWEdYRdhvdpA44TGHeyy375Psh0qetvFGOmTLfl7m--B0BdBlTM8M2ntOEt5qVWqmK2B43WlKRE2s_4_5OyimF7x74t8sYfyIRcmBO1rtTxqbldHzfImxFZuVno8xImNL2cnDKQuuN_jfbRfMja46J34BRoloq_OmIliDBY3Tb0PmFZAEb72LyglwnxbtSjD_TZSTKF-_2Mp_UBNxSGUD3TS2Qv0vDcm8XG36Zdozzav0NOuveSf1-jv-a7HbYvt757I8NrhVe07d92ALElbuFluV7huDF423obcWoNDASWL-yguPD3_mWZ4nmPbhBgju8WbLm8J1mDl20x0D_DZJha3AZtv0NXZ6Y-Tadr3W0hVQao2FSbnLqsMA4UFYo-5TLkaBhypnGbMApAwXPOKmJyqwgkYzktLSqMzrlzB3qKDZt3Y9wjn3i8iVjsA5ITXtSqNorrmtsisUVmCvkUfX2662hrSV7uOZ4DxpEei9EiUlaQkQV8HTO3WBV9GFI8gJx6R0dPDwPruWvYUJbVwvmxfJXLYn1OiIooKy7Kal5Yy41_nyUB6jocd6bpPXICT-tpZ8phWYDTlrBAJOowggVN1PD0QkuwlxdaH2IGIZ4LTBH3eTfuVPvqtsev7ACMYZ3CqBL3r6G53pIGcE1RGFBmdOZ4Btgp1xHs2-vDfKz-iZ2A_Uh-Sl-WH6KC9u7efwEZr1Qg4c1GO0JPJ6cXlfBT-dMB1xgVc55Nfo8Cz_wDnHkRP
link.rule.ids 108,230,315,733,786,790,870,891,2115,2236,12083,21416,24346,24965,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,76167,76168
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELagCMEF8SZQwEhInKyuH7vr5YIKokqg7QG1qDdr_Woj0U1otkhc-O3M7DqhViVukT127Mw34xlnPEPIWy1s9Ip71kYlmaqdZVaGFiTeNU4UOvCA95AHh9X0WH05KU_ShdsqhVWudeKgqP3C4R35DkKnAn9KiQ_LnwyrRuG_q6mExk1yS0mpEOf1ycbhArgWOiVq5LraAeNbMHQHWcOwvnf2wv1HdjAN-fuva-krx1QeQnnlTNq7T-4lY5Lujtx_QG6E7iG5PZaX_P2I_Jltatz2NPxKIKOLSM9brNx1BrqE9fBhvjqnbefpvEMbchU8HRIoBZqiuOh09p1x-q2koRtijMKKLsd3SzCGWiwzMU6Ar00C7QduPibHe5-PPk1ZqrfAbFU0PdO-VJE3XsKBBWpPRm5jCw2xaKKTMgCR9sqppvClsFXU0FzWoai948rGSj4hW92iC88ILdEvKoKLQKgK1ba29la4VoWKB2_5hLzPfnyzHHNrGMx2nfcACAxyziDnTGNEMSHv1pzajBt8GV1do_yIjMxmHxoWF6cmiaZxOmLavkaXsL5odVNYoYPkraqDkB6_DmFgUOJhRa5NDxdgp5g7y-yKBoymUlZ6QrYzSpBUl3evgWSSpliZf7iekDebbhyJ0W9dWFwONBrQDbuakKcj7jZbAhNMFLKGyesMkdme855ufjbkEZdgvNQVf_7_Zb0md6ZHB_tmf3b49QW5CwajwBg8Xm6Trf7iMrwEo6y3rwbJ-ws1uDjg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagCMSFdyFQwEhInLJJbCdxuJXCahdoVSGKKi5W_KIrutlVN4sEB347YydZremtt8geJxnl8zyizzMIveZEWs0yHdeW0ZiVSsaSmhp2vKoUSbnJjPsPeXhUTE7Yx9P8dKvVlyftKzkbNefzUTM789zK5VwlA08sOT48oGB1If1Oltom19EN2LOkHBL1zggDUlPe12jMeJFA3E1ilwnGFeDCVQAG15RS11wtOOd-HrgnX8X_sq3eclYhkXLLM43vou-DTh0h5edo3cqR-vNfuccrKX0P3enjVbzfidxH10zzAN3sOlj-foj-TjdtdFtsfvU4xguL57VrDnYG5ipu4WK2muO60XjWuDB1ZTT2NZoM7olieDL9Fmf4S45N42lMZoWX3dEoWIOl62TR3cAdaDG49YB5hE7GH74eTOK-pUMsi7RqY65zZrNKU_CJYFmpzaStYcCmlVWUGhDimilWpTonsrAchvPSpKVWGZO2oLtop1k05gnCuUu9UqMsCLKU1bUstSSqZqbIjJZZhN4GX1Ysu_IdwhXUDmdgbwuHEOEQIipB0gi9GWCwWefTJV5cknznUBLc3Q8sLn6I_vsJxa2rDFjxHN7PSl6lknBDs5qVhlDtHucwJpxRgTdSdX82AjR15bnEPqkgLstpwSO0F0iCMVDh9IBS0RujlWPxgRehnJEIvdpMu5WOYNeYxdrLcMooaBWhxx2oNyoNeyVCZQD3QOdwBkDsS5X3oH165ZUv0a3j92PxeXr06Rm6DdEqcQTALN9DO-3F2jyHiLCVL_ze_weetmNi
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Independent+evolution+of+macrophage-tropism+and+increased+charge+between+HIV-1+R5+envelopes+present+in+brain+and+immune+tissue&rft.jtitle=Retrovirology&rft.au=Gonzalez-Perez%2C+Maria+Paz&rft.au=O%27Connell%2C+Olivia&rft.au=Lin%2C+Rongheng&rft.au=Sullivan%2C+W+Matthew&rft.date=2012-03-15&rft.eissn=1742-4690&rft.volume=9&rft.spage=20&rft.epage=20&rft_id=info:doi/10.1186%2F1742-4690-9-20&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-4690&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-4690&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-4690&client=summon